Johannes Oosthuizen - Oct 28, 2022 Form 4 Insider Report for Merck & Co., Inc. (MRK)

Role
President, U.S. Market
Signature
/s/ Kelly E. W. Grez, as attorney-in-fact for Johannes Oosthuizen
Stock symbol
MRK
Transactions as of
Oct 28, 2022
Transactions value $
-$317,408
Form type
4
Date filed
11/1/2022, 04:30 PM
Previous filing
May 5, 2022
Next filing
Nov 7, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction MRK Common Stock Sale -$364K -3.63K -25.03% $100.21 10.9K Oct 28, 2022 Direct
transaction MRK Common Stock Options Exercise $92K +913 +8.39% $100.77 11.8K Oct 30, 2022 Direct
transaction MRK Common Stock Tax liability -$45.3K -450 -3.82% $100.77 11.3K Oct 30, 2022 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction MRK Restricted Stock Unit Options Exercise $0 -913 -49.95% $0.00 915 Oct 30, 2022 Common Stock 913 Direct F2, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Holdings include shares acquired in dividend reinvestment transactions.
F2 Each restricted stock unit represents a contingent right to receive one share of Merck & Co., Inc. common stock.
F3 These restricted stock units vest and are distributed as shares of Merck & Co., Inc. common stock in three equal installments on 10/30/2021, 10/30/2022 and 10/30/2023.